Dalton Transactions
Paper
4.0 Hz, 2H, bpm: 4,4′-H); 13C{1H} NMR (100 MHz, CD2Cl2,
273 K, δ ppm): 123.6 (s, bpm: 5,5′-C), 129.3 (t, J(C, P) = 4.0 Hz,
PPh3: meta-C), 130.9 (s, PPh3: para-C), 131.7 (t, J(C, P) = 22.0
Hz, PPh3: ipso-C), 133.1 (t, J(C, P) = 6.0 Hz, PPh3: ortho-C),
157.4 (s, bpm: 4,4′-C), 159.2 (s, bpm: 2,2′-C), 162.8 (s, bpm:
6,6′-C) (atomic numbering of the bpm ligand of 2a is the same
as that of bpy of 2); 31P{1H} NMR (160 MHz, CD2Cl2, 293 K,
δ ppm): 48.3 (s, PPh3); 19F NMR (376 MHz, CD2Cl2, 293 K,
δ ppm): −78.7 (s, CF3).
Spin–lattice relaxation time (T1, ms; 400 MHz) measurements
Variable temperature T1 data were obtained for complexes 1a
and 2a using the standard inversion recovery method at
400 MHz by applying a 180–τ–90° pulse sequence with a 5 K or
10 K temperature interval.20 Errors in the T1 data were calcu-
lated from the fitting of delay time (τ) vs. intensity plot. The
error in the T1(minimum) was calculated from fitting of the
T vs. T1 curve.
Partial deuteration experiments
Chart 2
Partial deuteration of complexes 1a and 2a was achieved by
bubbling HD gas (generated by a reaction between NaH and
D2O) through their CH2Cl2 solutions for 1 h at 213 K, 273 K,
and 288 K. The extent of incorporation of deuterium into the
cis-H2/hydride complexes was found to be maximum at 288 K.
bpm ligand, see Chart 2); 31P{1H} NMR (160 MHz, CD2Cl2, 293 K,
δ ppm): 61.3 (s, PPh3); IR (neat, cm−1): 1920 (νRuH); ESI-MS
(CH3CN): m/z 785 (M+ − H); Anal. Calc. for C44H38N4P2Ru:
C 67.25, H 4.87, N 7.13%; Found: C 67.43, H 4.50, N 6.80%.
Synthesis of cis,trans-[RuH(CO)(PPh3)2(N–N)][OTf] (N–N = bpy,
1b; bpm, 2b)
Synthesis of cis,trans-[RuH(η2-H2)(PPh3)2(N–N)][OTf] (N–N =
bpy, 1a; bpm, 2a)
CO gas was bubbled through CH2Cl2 (10 mL) solutions of cis,
To a suspension of cis,trans-[RuH2(PPh3)2(N–N)] (100 mg, trans-[RuH(η2-H2)(PPh3)2(N–N)][OTf] (N–N = bpy, 1a; bpm, 2a)
0.12 mmol 1; 100 mg, 0.11 mmol 2) in Et2O (10 mL) was added complexes (120 mg, 0.13 mmol 1a; 120 mg, 0.12 mmol 2a) at
HOTf (12 μL, 0.12 mmol) in an atmosphere of H2 or N2 or Ar. 273 K for 10 min. The solutions were then stirred at room
The dark violet (1) or dark black (2) colored suspension turned temperature for 30 min to allow for completion of the reaction
yellow (1a) or brown (2a) within 20 min of stirring. The reac- and then filtered through Celite. The resulting filtrates were
tion mixture was left undisturbed for the precipitate to settle concentrated to 1 mL and cis,trans-[RuH(CO)(PPh3)2(N–N)]-
down at the bottom of the Schlenk tube. Unreacted HOTf (if [OTf] (N–N = bpy, 1b; bpm, 2b) complexes were precipitated by
any) was removed by washing the resulting solid of complexes addition of Et2O (10 mL). Yield, 1b: 80 mg (64%); 2b: 62 mg
1a and 2a with Et2O (2 × 10 mL). Yield: complex 1a, 100 mg (50%). Complex 1b was reported by Luther and Heinekey
(90%); complex 2a, 60 mg (51%).
Characterization details of complex 1a: H NMR (400 MHz,
previously.9c
1
Characterization details of cis,trans-[RuH(CO)(PPh3)2(bpm)]-
1
CD2Cl2, 293 K, δ ppm): −9.93 (t, J(H, P) = 13.0 Hz, 3H, RuH3), [OTf] complex 2b: H NMR (400 MHz, CDCl3, 293 K, δ ppm):
6.91 (t, J(H, H) = 5.0 Hz, 2H, bpy: 5,5′-H), 7.22–7.36 (m, PPh3), −11.65 (t, J(H, P) = 19.0 Hz, 1H, RuH), 6.67 (t, J(H, H) = 5.0 Hz,
7.80 (t, J(H, H) = 5.0 Hz, 2H, bpy: 4,4′-H), 7.81 (d, J(H, H) = 1H, bpm: 3-H), 7.27–7.39 (m, PPh3), 7.57 (t, J(H, H) = 5.0 Hz,
5.0 Hz, 2H, bpy: 3,3′-H), 8.65 (d, J(H, H) = 5.0 Hz, 2H, bpy: 6,6′- 1H, bpm: 10-H), 7.75 (d, J(H, H) = 5.0 Hz, 1H, bpm: 2-H), 8.74
H); 13C{1H} NMR (100 MHz, CD2Cl2, 293 K, δ ppm): 123.4 (s, (d, J(H, H) = 5.0 Hz, 1H, bpm: 4-H), 8.83 (d, J(H, H) = 5.0 Hz,
bpy: 3,3′-C), 126.3 (s, bpy: 5,5′-C), 128.8 (t, J(C, P) = 4.0 Hz, 1H, bpm: 11-H), 9.24 (d, J(H, H) = 5.0 Hz, 1H, bpm: 9-H);
PPh3: meta-C), 130.4 (s, PPh3: para-C), 132.8 (t, J(C, P) = 13C{1H} NMR (100 MHz, CDCl3, 293 K, δ ppm): 124.2 (s, bpm:
21.0 Hz, PPh3: ipso-C), 133.3 (t, J(C, P) = 6.0 Hz, PPh3: ortho-C), 3-C), 124.5 (s, bpm: 10-C), 129.5 (t, J(C, P) = 4.0 Hz, PPh3: meta-
137.1 (s, bpy: 4,4′-C), 154.3 (s, bpy: 2,2′-C), 155.7 (s, bpy: 6,6′-C) C), 131.0 (t, J(C, P) = 22.0 Hz, PPh3: ipso-C), 131.2 (s, PPh3:
(for atomic numbering of the bpy ligand, see Chart 2); 31P{1H} para-C), 133.4 (t, J(C, P) = 6.0 Hz, PPh3: ortho-C), 158.0 (s, bpm:
NMR (160 MHz, CD2Cl2, 293 K, δ ppm): 48.9 (s, PPh3); 19F 4-C), 158.3 (s, bpm: 11-C), 159.8 (s, bpm: 6-C), 160.0 (s, bpm:
NMR (376 MHz, CD2Cl2, 293 K, δ ppm): −80 (s, CF3).
7-C), 161.8 (s, bpm: 2-C), 162.2 (s, bpm: 9-C), 203.5 (t, J(C, P) =
1
Characterization details of complex 2a: H NMR (400 MHz, 14.0 Hz, CO) (for atomic numbering of the bpy ligand, see
CD2Cl2, 293 K, δ ppm): −9.94 (t, J(H, P) = 12.0 Hz, 3H, RuH3), Chart 2); 31P{1H} NMR (160 MHz, CDCl3, 293 K, δ ppm): 45.2
7.03 (t, J(H, H) = 5.0 Hz, 2H, bpm: 5,5′-H), 7.23–7.42 (m, PPh3), (s, PPh3); 19F NMR (376 MHz, CDCl3, 293 K, δ ppm): −77.9 (s,
8.78 (d, J(H, H) = 5.0 Hz, 2H, bpm: 6,6′-H), 8.88 (d, J(H, H) = CF3); IR (neat, cm−1): 1943 (νCO); ESI-MS (CH3CN): m/z 813
This journal is © The Royal Society of Chemistry 2014
Dalton Trans., 2014, 43, 4726–4733 | 4731